FANTACUZZI, MARIALUIGIA
 Distribuzione geografica
Continente #
NA - Nord America 4.846
EU - Europa 3.361
AS - Asia 3.216
SA - Sud America 316
AF - Africa 54
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 2
Totale 11.797
Nazione #
US - Stati Uniti d'America 4.701
SG - Singapore 1.218
CN - Cina 871
IT - Italia 803
IE - Irlanda 413
TR - Turchia 385
UA - Ucraina 351
SE - Svezia 349
RU - Federazione Russa 314
VN - Vietnam 294
BR - Brasile 269
FR - Francia 254
GB - Regno Unito 250
IN - India 233
DE - Germania 198
PL - Polonia 126
FI - Finlandia 104
CA - Canada 92
ES - Italia 43
HK - Hong Kong 42
BD - Bangladesh 35
AT - Austria 34
MX - Messico 29
JP - Giappone 28
NL - Olanda 26
CZ - Repubblica Ceca 24
ZA - Sudafrica 22
BE - Belgio 21
LT - Lituania 16
PK - Pakistan 14
PT - Portogallo 14
ID - Indonesia 13
AR - Argentina 11
VE - Venezuela 11
IQ - Iraq 10
KR - Corea 10
PH - Filippine 9
SA - Arabia Saudita 8
CL - Cile 7
MA - Marocco 6
TW - Taiwan 6
CH - Svizzera 5
DZ - Algeria 5
GR - Grecia 5
HR - Croazia 5
KE - Kenya 5
MY - Malesia 5
AE - Emirati Arabi Uniti 4
CO - Colombia 4
EG - Egitto 4
ET - Etiopia 4
IR - Iran 4
JM - Giamaica 4
PE - Perù 4
CI - Costa d'Avorio 3
CR - Costa Rica 3
EC - Ecuador 3
IL - Israele 3
JO - Giordania 3
PY - Paraguay 3
TT - Trinidad e Tobago 3
UY - Uruguay 3
YE - Yemen 3
AL - Albania 2
AU - Australia 2
DO - Repubblica Dominicana 2
GT - Guatemala 2
HN - Honduras 2
KZ - Kazakistan 2
LB - Libano 2
NI - Nicaragua 2
NP - Nepal 2
SY - Repubblica araba siriana 2
TN - Tunisia 2
UZ - Uzbekistan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AZ - Azerbaigian 1
BB - Barbados 1
BG - Bulgaria 1
BH - Bahrain 1
BM - Bermuda 1
BZ - Belize 1
DK - Danimarca 1
EU - Europa 1
GD - Grenada 1
GY - Guiana 1
KH - Cambogia 1
KW - Kuwait 1
MM - Myanmar 1
OM - Oman 1
PA - Panama 1
PR - Porto Rico 1
QA - Qatar 1
RO - Romania 1
SK - Slovacchia (Repubblica Slovacca) 1
SO - Somalia 1
TG - Togo 1
TH - Thailandia 1
ZW - Zimbabwe 1
Totale 11.797
Città #
Singapore 910
San Jose 580
Chandler 501
Jacksonville 429
Dublin 407
Ashburn 394
Dallas 257
Izmir 244
Beijing 220
Dearborn 210
Chieti 209
Princeton 169
Southend 148
Nanjing 128
Los Angeles 116
The Dalles 116
Santa Clara 106
Ho Chi Minh City 100
Kraków 89
Cambridge 82
Ann Arbor 79
New York 72
Wilmington 69
Nanchang 63
Council Bluffs 62
Hanoi 59
Munich 55
Altamura 49
Tongling 48
Moscow 42
Buffalo 37
Hong Kong 36
Warsaw 35
Pescara 34
São Paulo 34
Boardman 33
Hebei 31
Orem 31
Bosa 30
Shenyang 30
Teramo 30
Helsinki 27
Redondo Beach 27
Atlanta 26
Da Nang 25
Jiaxing 25
Denver 24
Brno 23
Jinan 23
Vienna 23
Brooklyn 22
Chennai 22
Kunming 22
Milan 22
Rome 22
Stockholm 22
Washington 22
Brussels 21
Toronto 21
Houston 20
London 20
Montreal 20
Ottawa 20
Tianjin 20
Tokyo 20
Changsha 19
Kocaeli 17
Hefei 16
Amsterdam 15
Johannesburg 15
Poplar 15
Haiphong 14
Turku 14
Chicago 13
Manchester 13
Woodbridge 13
Hangzhou 12
Mexico City 12
San Francisco 12
Nuremberg 11
Ankara 10
Norwalk 10
Augusta 9
Biên Hòa 9
Falls Church 9
Ningbo 9
Seattle 9
Dong Ket 8
Porto 8
Redwood City 8
Rio de Janeiro 8
Zhengzhou 8
Belo Horizonte 7
Changchun 7
Como 7
Frankfurt am Main 7
Guangzhou 7
New Delhi 7
Nogarole Vicentino 7
Phoenix 7
Totale 7.285
Nome #
Anticancer Activity of Stilbene-Based Derivatives 193
Synthesis of 2-aryloxypropanoic acids analogues of clofibric acid and assignment of the absolute configuration by 1H NMR spectroscopy and DFT calculations 192
Synthesis and antibacterial evaluation of oxazolidin-2-ones structurally related to linezolid 189
Discovery of N-{3-[(ethanimidoylamino)methyl]benzyl}-L-prolinamide dihydrochloride: A new potent and selective inhibitor of the inducible nitric oxide synthase as a promising agent for the therapy of malignant glioma 188
Valutazione biologica dei derivati dell'acido clofibrico come potenziali ligandi PPARs 178
Synthesis, biological activity, and docking studies of novel acetamidines as selective modulators of nitric oxide synthase 172
Titanium-Promoted Acylation of Sulfonamides to N-Acylsulfonamide PPAR Antagonists 171
Synthesis and Biological Evaluation of 2-Heteroarylthioalkanoic Acid Analogues of Clofibric Acid as Peroxisome Proliferator-Activated Receptor alfa Agonists 167
Synthesis and structure-activity relationships of fibrate-based analogues inside PPARs 167
Recent developments of amidine-like compounds as selective NOS inhibitors 167
Antiglioma Activity of Aryl and Amido-Aryl Acetamidine Derivatives Targeting iNOS: Synthesis and Biological Evaluation 164
Synthesis and biological evaluation of potential Nitric Oxide Synthase inhibitors 163
Novel Phenyldiazenyl Fibrate Analogues as PPAR α/γ/δ Pan-Agonists for the Amelioration of Metabolic Syndrome 161
Benzothiazole-based N-(phenylsulfonyl)amides as a novel familyof PPARa antagonists 160
Cytotoxic effect of a family of Peroxisome Proliferator-Activated Receptor antagonists in colorectal and pancreatic cancer cell lines 159
Candida rugosa lipase-catalysed kinetic resolution of 2-substituted-aryloxyacetic esters with dimethylsulfoxide and isopropanol as additives 157
Asymmetric Synthesis of Arylpropionic Acids and Aryloxy Acids by Using Lactamides as Chiral Auxiliaries 157
Discovery of new FXR agonists based on 6-ECDCA binding properties by virtual screening and molecular docking 157
The Selective Acetamidine-Based iNOS Inhibitor CM544 Reduces Glioma Cell Proliferation by Enhancing PARP-1 Cleavage In Vitro 157
Enantiomeric separation of Gemfibrozil chiral analogues by capillary electrophoresis with heptakis(2,3,6-tri-O-methyl)-beta-cyclodextrin as chiral selector 156
Synthesis and biological evaluation of gemfibrozil chiral analogs as potential PPARa agonists 150
Druggability profile of stilbene-derived PPAR agonists: Determination of physicochemical properties and PAMPA study 150
PPARα agonists based on stilbene and its bioisosteres: Biological evaluation and docking studies 148
Syntesis and pharmacological evaluation of fibrates analogues as cardiovascular agents 146
Synthesis and biological characterization of 3-(imidazol-1-ylmethyl)piperidine sulfonamides as aromatase inhibitors 146
Fibrate-derived N-(methylsulfonyl)amides with antagonistic properties on PPARa 145
Synthesis and cytotoxic effects on pancreatic cancer cells of resveratrol analogs 144
Enantiomeric separation of some demethylated analogues of clofibric acid by capillary zone electrophoresis and nano-liquid chromatography 143
Sintesi e valutazione biologica di analoghi eterociclici del gemfibrozil a potenziale attività cardiovascolare 141
Indazole, Pyrazole, and Oxazole Derivatives Targeting Nitric Oxide Synthases and Carbonic Anhydrases 139
Sulfonimide and Amide Derivatives as Novel PPARα Antagonists: Synthesis, Antiproliferative Activity, and Docking Studies 137
Synthesis of naphthyl-, quinolin- and anthracenyl analogues of clofibric acid as PPARα agonists 136
Synthesis and biological evaluation of new acetamidines as selective inhibitors of Nitric Oxide Synthases 134
Selective Acetamidine-Based Nitric Oxide Synthase Inhibitors: Synthesis, Docking, and Biological Studies 134
Amidine-Based Compounds Affecting L-Arginine Metabolism 134
Selective inhibition of inducible Nitric Oxide Synthase by derivatives of acetamidine 133
Novel aminobenzyl-acetamidine derivative modulate the differential regulation of NOSs in LPS induced inflammatory response: Role of PI3K/Akt pathway 132
Fibrate-based N-acylsulphonamides targeting carbonic anhydrases: synthesis, biochemical evaluation, and docking studies 131
Discovery of gemfibrozil analogues that activate PPARa and enhance the expression of gene CPT1A involved in fatty acids catabolism 130
Starting a new series of acetamidines as Nitric Oxide Sinthase inhibitors 129
Amidine-Based Bioactive Compounds for the Regulation of Arginine Metabolism 129
Time factor in antiretroviral adherence: analysis of adherence to single-tablet regimens versus multiple-tablet regimens over a 5-year period 129
Analoghi eterociclici dell’acido clofibrico: sintesi, attività antiaggregante piastrinica e separazione in elettroforesi capillare 128
null 128
Synthesis, characterization and evaluation of gemfibrozil-stilbene hybrid as antioxidant agent 128
Structural development studies of PPARs ligands based on tyrosine scaffold 127
Synthesis and biological evaluation of novel acetamidines as nitric oxide inhibitors 126
Benzothiazole Derivatives Endowed with Antiproliferative Activity in Paraganglioma and Pancreatic Cancer Cells: Structure-Activity Relationship Studies and Target Prediction Analysis 125
Dual-PPAR agonists based on stilbene scaffold: synthesis and biological evaluation 125
Selective Inhibition of iNOS by Benzyl- and Dibenzyl Derivatives of N-(3-Aminobenzyl)acetamidine. 124
N-Substituted acetamidines and 2-methylimidazole derivatives as selective inhibitors of neuronal nitric oxide synthase 123
Sintesi di esteri del gemfibrozil donatori di ossido nitrico 123
Enantioseparazione di analoghi chirali dei fibrati in Elettroforesi Capillare e nano-Cromatografia Liquida 122
Platelet aggregation: synthesis and pharmacological evaluation of clofibric acid analogues 121
Effect of stilbene and chalcone scaffolds incorporation in clofibric acid on PPARα agonistic activity 120
Selective inhibition of iNOS by benzyl- and dibenzyl derivatives of N-(3-aminobenzyl)acetamidine on cellular line H2C9 119
Synthesis and cytotoxicity evaluation of novel amide and sulfonimide PPARa antagonists 117
Coumarin-Based Dual Inhibitors of Human Carbonic Anhydrases and Monoamine Oxidases Featuring Amino Acyl and (Pseudo)-Dipeptidyl Appendages: In Vitro and Computational Studies 115
Azo derivatives of monoterpenes as anti-Helicobacter pylori agents: from synthesis to structure-based target investigation 112
Design, synthesis and biological evaluation of imidazole and triazole-based carbamates as novel aromatase inhibitors 112
Design, synthesis and biological evaluation of aromatase inhibitors based on sulfonates and sulfonamides of resveratrol 112
Sintesi di derivati eterociclici dell’acido clofibrico a potenziale attività antiaggregante piastrinica 111
A Novel Prodrug of a nNOS Inhibitor with Improved Pharmacokinetic Potential 111
Novel Phenyldiazenyl Fibrate Analogues as PPAR Agonists: Design, Synthesis and Pharmacological Evaluation 110
Synthesis, biological evaluation, and docking study of indole aryl sulfonamides as aromatase inhibitors 110
Synthesis of novel benzothiazole amides: Evaluation of PPAR activity and anti-proliferative effects in paraganglioma, pancreatic and colorectal cancer cell lines 110
In vitro protective effects of resveratrol and stilbene alkanoic derivatives on induced oxidative stress on c2c12 and mcf7 cells 109
Capillary electrophoretic enantioseparation of gemfibrozil analogues by use of TM-b-cyclodextrin as chiral selector 108
Synthesis and pharmacological evaluation of gemfibrozil chiral analogues as cardiovascular agents 108
Antiviral Peptides as Anti-Influenza Agents 107
Design, synthesis and biological evaluation of novel acetamidines as selective inducible nitric oxide synthase inhibitors 106
Methods to Evaluate the Activity of Nitric Oxide Synthase 105
Separazione enantiomerica di analoghi chirali dell'acido clofibrico mediante elettroforesi capillare 104
Reversed-phase high-performance liquid chromatography method with fluorescence detection to screen nitric oxide synthases inhibitors. 103
Synthesis, structure-activity relationships and molecular docking studies of phenyldiazenyl sulfonamides as aromatase inhibitors 103
Fibrate-Based Analogues as PPARs Agonists: Synthesis and Structure–Activity Relationships 102
PPAR Ligands Containing Stilbene Scaffold 102
QSAR, QSPR and QSRR in terms of 3-D-MoRSE descriptors for in silico screening of clofibric acid analogues 101
A novel life for antitumor combretastatins: Recent developments of hybrids, prodrugs, combination therapies, and antibody-drug conjugates 98
Screening of NOS activity and selectivity of newly synthesized acetamidines using RP-HPLC 98
In vitro evaluation of a new selective iNOS inhibitor on normal rat astrocytes and C6 rat glioma cells 96
Synthetic Approach to Phenylalanine-Proline, and Tyrosine-Proline Hybrid Amino Acids 94
PPAR Ligands Induce Antiviral Effects Targeting Perturbed Lipid Metabolism during SARS-CoV-2, HCV, and HCMV Infection 94
N-Acylsulfonylamides as a new class of PPARa antagonists 91
Sintesi, relazioni struttura-attività e docking di nuovi inibitori delle Ossido Nitrico Sintasi 90
Geometric Isomerism of an Acetamidino Derivative Determined by NMR Investigations 88
Enantiomeric separation of some chiral analogues of clofibric acid by capillary zone electrophoresis and nano-liquid chromatography 87
Benzenesulfonamide derivatives as Vibrio cholerae carbonic anhydrases inhibitors: a computational-aided insight in the structural rigidity-activity relationships 86
Pegylation approach applied to erlotinib–carbonic anhydrase inhibitors hybrids towards anticancer agents 82
Development of CDK4/6 Inhibitors: A Five Years Update 82
Synthesis, in vitro evaluation, and molecular modelling investigation of benzenesulfonimide Peroxisome Proliferator-Activated Receptors α antagonists 81
Protein-protein interactions at a glance: Protocols for the visualization of biomolecular interactions 80
HDAC Inhibitors for the Therapy of Triple Negative Breast Cancer 79
Novel Synthetic Strategies for the Development of Tryptophan-Proline Chimeras, Useful Tool for Drug Discovery 77
Resveratrol Analogues as Dual Inhibitors of Monoamine Oxidase B and Carbonic Anhydrase VII: A New Multi-Target Combination for Neurodegenerative Diseases? 66
A Comprehensive Computational Insight into the PD-L1 Binding to PD-1 and Small Molecules 63
Inhibition of Human Coronavirus 229E by Lactoferrin-Derived Peptidomimetics 62
New azolyl-derivatives as multitargeting agents against breast cancer and fungal infections: synthesis, biological evaluation and docking study 62
Erlotinib-containing benzenesulfonamides as anti-Helicobacter pylori agents through carbonic anhydrase inhibition 61
Resveratrol-based compounds and neurodegeneration: Recent insight in multitarget therapy 57
Totale 12.306
Categoria #
all - tutte 46.115
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 46.115


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202139 0 0 0 0 0 0 0 0 0 0 0 39
2021/2022609 10 11 22 95 54 22 23 52 97 20 70 133
2022/20231.441 103 202 108 136 133 305 71 110 178 17 52 26
2023/2024693 51 21 61 14 43 216 166 10 4 30 9 68
2024/20251.645 73 303 268 21 38 90 64 96 161 73 237 221
2025/20264.028 309 129 444 514 478 218 709 270 396 316 192 53
Totale 12.368